can be suppressed by systematic inflammation and malnutrition.
Recent studies have demonstrated that serum albumin functions as an antioxidant in the host defense mechanism. 7, 8 The ALB-dNLR (albumin-dNLR) score consists of the serum albumin and derived neutrophil to lymphocyte ratio, indicating nutritional status and inflammatory conditions that are associated with the disease activity of RA patients, while there is no investigation about the associations between ALB-dNLR score and disease activity in RA patients.
Accordingly, we retrospectively collected clinical and laboratory data of RA patients, then investigate the correlation of the ALBdNLR score with the laboratory characteristics and disease activities of RA patients.
| MATERIAL S AND ME THODS

| Patients identification
We retrospectively collected data on 286 RA patients in our hospital between January 2012 and August 2018. RA patients were diagnosed according to the rheumatoid arthritis classification criteria published in 2010 (American College of Rheumatology/European League Against Rheumatism). 9 We collected the laboratory data and clinical characteristics, including age, sex, smoking and alcohol habits, disease duration, presence of morning stiffness, rheumatoid factor (RF), C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), albumin, leukocyte and neutrophils counts. As multiple diseases could affect serum albumin, leukocyte, and neutrophils, one hundred and fifty-nine patients were excluded for having other autoimmune diseases, malignancies, infections, hypertension, diabetes mellitus, or cardiovascular diseases. Finally, we included 127 RA patients with complete information in the study and categorized them into three groups according the DAS28 score criteria: a score of DAS28 ≤ 3.2 was defined as low disease activity, 3.2 < DAS28 ≤ 5.1 as moderate disease activity, and DAS28 > 5.1
as high disease activity. 10 In addition, 155 healthy subjects and 155
OA patients were included in this study. The present study was approved by the institutional ethics committee of Taizhou hospital of Zhejiang Province.
| dNLR and ALB-dNLR score
The derived neutrophil to lymphocyte ratio (dNLR) was calculated as neutrophils to (leukocyte-neutrophil count). The cutoff values of serum albumin concentrations and dNLR were set at 37.6 g/L and 1.37, respectively, based on the ROC curve. The ALB-dNLR score was classified into three groups based on each cutoff value of serum albumin and dNLR as follows: an ALB-dNLR score of 2 for patients with both hypoproteinemia (≤37.6 g/L) and high dNLR (>1.37), an ALB-dNLR score of 1 for those with either of the two abnormities, and an ALB-dNLR score of 0 for those with neither hypoproteinemia nor high dNLR. We also divided 127 RA patients into three groups according to the DAS28 score. The correlations between ALB-dNLR score and laboratory indexes were analyzed by the Spearman's correlation test. The receiver operating characteristic (ROC) curve was calculated to assess the prediction ability of RA by the ALB-dNLR. P value <0.05 was considered as statistically significant. The analysis was performed using SPSS 22.0 statistical software (SPSS Inc., Chicago, IL, USA).
| Statistical analysis
| RE SULTS
| Comparison of ALB-dNLR score between RA patients, OA patients, and healthy controls
The main clinical and laboratory characteristics of 127 RA patients were summarized in Table 1 We compared the laboratory data among RA patients, OA patients and healthy group. As shown in Table 2 , the median age of the RA patients was 56 years, which was lower than that of the healthy group (58 years) and the OA group (63 years). In the RA patients, the median albumin concentration was 39.8 g/L, significantly lower than that of the OA patients (41.5 g/L) (P < 0.001) and the healthy controls (45.9 g/L) (P < 0.001). In contrast, the level of dNLR was significantly higher in RA patients than in the OA patients (P < 0.001) or healthy controls (P < 0.001). According to the system of the ALB-dNLR score, 22
(17.3%), 66 (52.0%), and 39 (30.7%) RA patients had an ALB-dNLR score of 0, 1, and 2, respectively. In the OA patients, 66 (42.6%), 81 (52.3%), and 8 (5.1%) had an ALB-dNLR score of 0, 1, and 2, respectively. In the 155 healthy controls, 83 (53.5%) had an ALB-dNLR score of 0, and 72 (46.5%) had an ALB-dNLR score of 1 ( Table 2) . A high ALB-dNLR score was significantly more likely to be present in the RA patients, than in the OA patients and healthy controls (P < 0.001).
| Association of the ALB-dNLR score with disease activity of RA
The DAS28 score was used to classified RA patients into three groups (low, moderate, and high disease activity). 18.9% (n = 24) patients were classified as low disease activity (DAS28 ≤ 3.2), 55.9%
(n = 71) as moderate disease activity (3.2 < DAS28 ≤ 5.1), and 25.2%
(n = 32) as high disease activity (DAS28 > 5.1). The gender, smoking habits, alcohol habits, and disease duration among three groups
were not significantly different. The results showed that three (12.5%) patients had an ALB-dNLR score of 2 among the 24 patients in the DAS28 ≤ 3.2 group, 18 (25.4%) patients had an ALB-dNLR score of 2 among the 71 patients in the 3.2 < DAS28 ≤ 5.1 group, and 18 (56.2%) patients had an ALB-dNLR score of 2 among the 32 patients in the DAS28 > 5.1 group. The result demonstrated that patients with serious disease activity have higher proportion of high ALB-dNLR scores (P < 0.001) (Table 3 ). Additionally, we described in detail the usage of medication in the three groups of RA patients and found that the use of medication among different levels of disease activity of RA patients has no significant difference (P > 0.05),
as shown in Table 3 . (r = 0.323, P < 0.001), CRP (r = 0.463, P < 0.001), and ESR (r = 0.382, P < 0.001). Moreover, we also found ALB-dNLR score was positively correlated with other laboratory data such as platelet count (r = 0.195, P = 0.028) and IgA (r = 0.208, P = 0.034) and negatively correlated with total protein (r = −0.414, P < 0.001).
| Correlation between the ALB-dNLR score and laboratory data of RA patients
To assess the diagnostic ability of the ALB-dNLR score in RA and OA patients and compare it with serum albumin and dNLR, we gener- 
| D ISCUSS I ON
The ALB-dNLR score, consisting of serum albumin and the derived neutrophil to lymphocyte ratio (dNLR), was established for measuring immune system and nutritional status. We therefore investigated the relationship between the ALB-dNLR score and the disease activity of RA in our study. The results demonstrated that RA patients had higher ALB-dNLR scores than OA patients and healthy controls.
A higher ALB-dNLR score was positively correlated with serious RA disease activity.
The roles of malnutrition and inflammation in regulating autoimmune diseases have been reported. Derived NLR (dNLR) was initially defined by Proctor et al as the neutrophil count to (leukocyteneutrophil count). 3 The leukocyte-neutrophil value in the denominator is broadly mixing lymphocytes and monocytes, which have potentially inversed effects from each other. Several studies have regarded dNLR as an inflammation marker that can reflect the severity of systematic inflammation in several cancers, such as non-small cell lung cancer, 11 colorectal cancer, 12 and breast cancer. 13 Serum albumin has been considered to have anti-inflammatory and possible immunomodulatory properties 14 ; therefore, if albumin synthesis was restricted by systematic inflammation, damage to the immune defense system of the patient could occur. 15 Moreover, previous ALB-dNLR score, Albumin-dNLR score; CRP, C-reactive protein; DAS28 score, 28-joint count Disease Activity Score; DMARDs, disease-modifying anti-rheumatic drugs; dNLR (Derived neutrophil to lymphocyte ratio), Neutrophil count to (Leukocyte-Neutrophil count) ratio; ESR, Erythrocyte sedimentation rate; NSAIDs, non-steroidal anti-inflammatory drugs; RF, rheumatoid factor. Quantitative data are presented as median (IQR) or n (%), depending on the distribution.
TA B L E 3
in RA patients who were also suffering from malnutrition. 16 Several studies have reported that malnutrition is a common symptom in RA patients, and impairment of nutrition may affect the immune system, physical functions, and pathologic condition of RA. 17 It has been reported that the low concentration of albumin in RA patients may owing to excessive albumin consumption caused by inflammatory substances. 16, 18 Rheumatoid arthritis is a chronic representative autoimmune disease associated with inflammation and nutritional status. 19, 20 In our study, we assessed the ALB-dNLR score, which was based on albumin and dNLR in RA patients. The results found that RA patients tend to have higher ALB-dNLR scores than OA patients or healthy controls. To confirm the relationship between the ALB-dNLR score and the disease activity of RA patients, we investigated the ALBdNLR score among different level of disease activity of RA patients:
high disease activity patients had higher ALB-dNLR scores than those in states of moderate or low disease activity, indicating a gradual impairment of the immune system and nutritional status along with increased disease activity. In addition, we also found a significant positive correlation between ALB-dNLR score and DAS28 in RA patients. As serum albumin might be affected by drug therapy, such as NSAIDs, methotrexate, and leflunomide, [21] [22] [23] we included the medication usage over the past two months in our study. The results showed that the medication usage among the three different disease activity groups exhibited no significant differences.
As is well known, ESR and CRP are considered as traditional inflammatory markers closely related to disease activity in RA patients. Our data demonstrated that ALB-dNLR was positively associated with CRP and ESR, as well as the DAS28 score. Moreover, we also observed that the ALB-dNLR score was positively correlated with platelet count and IgA, while no correlations were detected for RF and anti-CCP. We also observed that the diagnostic AUC of ALBdNLR was superior to albumin and dNLR in distinguishing RA from OA patients, indicating that a combination of albumin and dNLR can improve the diagnostic effectiveness of RA. This is consistent with a previous study performed by Liu et al demonstrating that the combination of albumin and dNLR can improve the diagnostic effectiveness of pancreatic cancer (PCC). 6 However, there were several limitations in our study, as it was a retrospective and single center study. The number of RA patients was small as we excluded patients with any concomitant diseases that may become the potential confounding factors. Therefore, further prospective studies including a large sample are needed to validate the clinical value of ALB-dNLR in RA patients. In addition, as the follow-up was not evaluated, its correlation with prognosis of RA was not analyzed.
TA B L E 4
Correlation between ALB-dNLR score and laboratory variables in RA patients The analysis was conducted by Spearman's correlation. ALB-dNLR score, Albumin-dNLR score; Anti-CCP, anti-cyclic citrullinated peptide antibody; CRP, C-reactive protein; DAS28 score, 28-joint count Disease Activity Score; ESR, Erythrocyte Sedimentation Rate; RF, rheumatoid factor.
F I G U R E 1
The areas under the curves (AUC) of ALB-dNLR (A), dNLR (B), and ALB (C) in RA patients compared to OA patients. ALB, albumin; dNLR, derived neutrophil to lymphocyte ratio; OA, osteoarthritis; RA, rheumatoid arthritis
In conclusion, the present study demonstrated that ALB-dNLR score was significantly increased in patients with RA and positively correlated with disease activity. Since ALB-dNLR was determined by serum albumin and dNLR, which can be calculated easily and are readily available as routine laboratory tests, it could be a simple and effective clinical indicator that may be associated with risk for RA incidence. 
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